Pakistan Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Pakistan Pharmaceuticals and Healthcare Report Q3 2013 May 15th 2013, 00:00 BMI View: Increased longevity in developed markets translates into an increased demand for aged care healthcare services and medicines. However, in emerging markets such as Pakistan, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades - continuing to limit revenue earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases. Headline Expenditure Projections ? Pharmaceuticals: PKR189.21bn (US$2.03bn) in 2012 to PRK209.65bn (US2.11bn) in 2013; +10.8% in local currency terms and +3.9% in US dollar terms. ? Healthcare: PKR523.27bn (US$5.60bn) in 2012 to PKR595.84bn (US$5.98bn) in 2013; +13.9% … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=96083. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/pakistan-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions